Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/17/24 19:04 | 1/16/24 | MORF | Health | Drug | Pharmaceutical Preparations | Tipirneni Praveen P. | MA | DO | CEO | 7 | S.d | -2,580 | 47.49 | 0 | -54 | 42 | D | |||||||||||||||
1/17/24 19:03 | 1/16/24 | MORF | Health | Drug | Pharmaceutical Preparations | Schegerin Marc | MA | O | CFO,COO | 4 | S.d | -6,238 | 49.50 | 0 | -126 | 37 | D | |||||||||||||||
1/17/24 19:02 | 1/16/24 | MORF | Health | Drug | Pharmaceutical Preparations | Rogers Bruce | MA | O | P | 4 | S.d | -2,580 | 45.82 | 0 | -56 | 142 | D | |||||||||||||||
1/17/24 19:01 | 1/16/24 | MORF | Health | Drug | Pharmaceutical Preparations | Farrell Robert E Jr | MA | O | SVP Fina | 5 | S.d | -2,562 | 46.51 | 0 | -55 | 35 | D | |||||||||||||||
1/17/24 19:00 | 1/16/24 | MORF | Health | Drug | Pharmaceutical Preparations | Devaul William | MA | O | GC,Secre | 3 | S.dm | -824 | 50.96 | 0 | -16 | 23 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |